Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-20 | Arthur J. Higgins, 64 years old, President and Chief Executive Officer of Assertio Therapeutics, Inc. Member of the Compensation and Safety, Health and Environment Committees. Director compensation total $280,621. |
| 2021-03-19 | Consultant to Blackstone Healthcare Partners L.L.C. of The Blackstone Group L.P., an investment company sourcing, analyzing and overseeing investments in the area of pharmaceuticals and medical products. Director of Ecolab since 2010. Member of the Compensation and Safety, Health and Environment Committees. |
| 2022-03-18 | Mr. Higgins has extensive leadership experience in the global healthcare market. |
| 2023-03-17 | Arthur J. Higgins, Independent Director: Yes, Age: 67, Board Member since: 2010, Board Committees: Compensation & Human Capital Management, Safety, Health & Environment, Director Compensation Table: Total $300,512. |
| 2024-03-15 | Mr. Higgins brings to the Board extensive leadership experience and enterprise risk management in the healthcare and life sciences industries. Through leadership positions with large life sciences developers and manufacturers in both the United States and Europe, Mr. Higgins has gained deep knowledge of the life sciences and healthcare businesses and the strategies for developing and marketing products in these highly regulated industries. This background allows him to provide valuable insight to Ecolab’s life sciences business, including quality and operating risk management, and expertise related to complex chemical manufacturing environments. In addition, his global perspective from years of operating global businesses and his background in working with high growth companies informs Ecolab’s ambitions for sustainable growth. |
| Filing Date | Source Excerpt |
|---|---|
| 2003-10-28 | Arthur J. Higgins, has served as the Company's President, Chief Executive Officer and a director of the Company since May 31, 2001, and Chairman of the Board since December 3, 2001... Employee directors receive no compensation for their service on our Board of Directors. |
| 2004-10-28 | Arthur J. Higgins (4)(7) ................... 48 2001 Director (4) Member of the Executive Committee During the fiscal year ended June 30, 2004, the Company expensed and recorded $179,088 in Independent Directors Fees, a summary of which follows: Arthur Higgins (1)............................................. $ 8,293 Mr. Higgins resigned from the Company as Chief Executive Officer in May 2004. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-03-30 | Consultant, Blackstone Healthcare Partners of The Blackstone Group, since June 2010. Prior to that, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry. |
| 2018-04-02 | Arthur J. Higgins has extensive senior leadership experience in the global healthcare market. Through leadership positions with large healthcare developers and manufacturers in both the U.S. and Europe, he has gained deep knowledge of the healthcare market and the strategies for developing and marketing products in this highly regulated area. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry. |
| 2019-03-27 | Arthur J. Higgins has extensive senior leadership experience in the global healthcare market. Through leadership positions with large healthcare developers and manufacturers in both the U.S. and Europe, he has gained deep knowledge of the healthcare market and the strategies for developing and marketing products in this highly regulated area. |
| 2020-03-25 | Arthur J. Higgins graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry. He has extensive senior leadership experience in the global healthcare market. |
| 2021-03-31 | Arthur J. Higgins has extensive senior leadership experience in the global healthcare market. Through leadership positions with large healthcare developers and manufacturers in both the U.S. and Europe, he has gained deep knowledge of the healthcare market and the strategies for developing and marketing products in this highly regulated area. |
| 2022-03-29 | He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry. |
| 2023-03-30 | He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry. |
| 2024-03-27 | Arthur J. Higgins has extensive senior leadership experience in the global healthcare market. Through leadership positions with large healthcare developers and manufacturers in both the U.S. and Europe, he has gained deep knowledge of the healthcare market and the strategies for developing and marketing products in this highly regulated area. |
Data sourced from SEC filings. Last updated: 2026-02-03